Alternative Data for Semler Scientific
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 96 | Sign up | Sign up | Sign up |
| Webpage traffic | 13,000 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 20 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,338 | Sign up | Sign up | Sign up |
| X Mentions | 13 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 74 | Sign up | Sign up | Sign up |
About Semler Scientific
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
| Price | $20.33 |
| Target Price | Sign up |
| Volume | 1,620,000 |
| Market Cap | $348M |
| Year Range | $15.21 - $45.97 |
| Dividend Yield | 0% |
| PE Ratio | 5.04 |
| Analyst Rating | 0% buy |
| Industry | Medical Devices |
In the news
Strive Announces the Completion of Semler Scientific AcquisitionJanuary 16 - GlobeNewswire |
|
 |
Strive completes acquisition of Semler ScientificJanuary 15 - Yahoo |
 |
Vivek Ramaswamy’s Strive to add over 5,000 Bitcoin in approved Semler Scientific dealJanuary 13 - Crypto Briefing |
Strive, Inc. (Nasdaq: ASST) and Semler Scientific (Nasdaq: SMLR) Announce Shareholder Approval for Acquisition of Semler ScientificJanuary 13 - GlobeNewswire |
|
 |
New York hedge fund acquires over $125,000 in Bitcoin treasury company Strive sharesJanuary 26 - Crypto Briefing |
 |
Vivek Ramaswamy’s Strive Looks To Raise $150 Million For Further Bitcoin AcquisitionsJanuary 22 - ZyCrypto |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 7.5M | 640,000 | 6.9M | 17M | 25M | -0.299 |
| Q2 '25 | 8.2M | 740,000 | 7.5M | 67M | -1.9M | -0.230 |
| Q1 '25 | 8.8M | 940,000 | 7.9M | -65M | -74M | -6.743 |
| Q4 '24 | 12M | 1.1M | 11M | 29M | 3.6M | 3.409 |
| Q3 '24 | 14M | 1.2M | 12M | 5.6M | 6.5M | 0.590 |
Insider Transactions View All
| Murphy-Chutorian Douglas filed to sell 67,331 shares at $20.1. November 18 '25 |
| Murphy-Chutorian Douglas filed to sell 54,594 shares at $20.7. November 18 '25 |
| Murphy-Chutorian Douglas filed to sell 31,396 shares at $30.5. August 26 '25 |
| Murphy-Chutorian Douglas filed to sell 55,000 shares at $63.8. December 12 '24 |
| Murphy-Chutorian Douglas filed to sell 76,815 shares at $60.3. December 12 '24 |
Similar companies
Read more about Semler Scientific (SMLR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions, customer reviews & linkedin employees.
FAQ - Semler Scientific
The Market Cap of Semler Scientific is $348M.
As of today, Semler Scientific's PE (Price to Earnings) ratio is 5.04.
Currently, the price of one share of Semler Scientific stock is $20.33.
The SMLR stock price chart above provides a comprehensive visual representation of Semler Scientific's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Semler Scientific shares. Our platform offers an up-to-date SMLR stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Semler Scientific (SMLR) does not offer dividends to its shareholders. Investors interested in Semler Scientific should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Semler Scientific are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
